Article Information
History
- November 23, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 23, 2020 - 10:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Puya Dehgani-Mobaraki, M.D, M.S(ORL)1,*,
- Asiya Kamber Zaidi, M.D, M.S (ORL), F.W.A.M.S2,
- Annamaria Porreca3,
- Alessandro Floridi, M.Pharm4 and
- Emanuela Floridi4
- 1President of Associazione Naso Sano, Umbria region, Italy
- 2Senior Registrar, M.G.M Medical College and M.Y Hospital, Indore, M.P, India Member, Associazione Naso Sano, Umbria region, Italy
- 3Ph.D student at Department of Economics, University “G.d’Annunzio”, chieti-Pescara, Italy
- 4Laboratory of Nuclear Lipid BioPathology, Centro Ricerche Analisi Biochimico Specialistiche, Perugia, Italy
- ↵*Corresponding author Email: dehganipuya{at}gmail.com
Posted November 23, 2020.
Antibody persistency and dynamic trend after SARS-CoV-2 infection over 8 months
